Vincent J. Picozzi

7.3k total citations · 1 hit paper
130 papers, 4.5k citations indexed

About

Vincent J. Picozzi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vincent J. Picozzi has authored 130 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Oncology, 49 papers in Cancer Research and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vincent J. Picozzi's work include Pancreatic and Hepatic Oncology Research (84 papers), Cancer Genomics and Diagnostics (46 papers) and Renal cell carcinoma treatment (21 papers). Vincent J. Picozzi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (84 papers), Cancer Genomics and Diagnostics (46 papers) and Renal cell carcinoma treatment (21 papers). Vincent J. Picozzi collaborates with scholars based in United States, Spain and Canada. Vincent J. Picozzi's co-authors include L. William Traverso, Richard A. Kozarek, John A. Glaspy, John Grous, Mark G. Kris, Gary H. Lyman, Ronald G. Stoller, Morgan E. Stewart, Imad A. Tabbara and Roy E. Smith and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Vincent J. Picozzi

124 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1991 1.1k citations Vincent J. Picozzi et al. profile →

Peers

Countries citing papers authored by Vincent J. Picozzi

Since Specialization

Citations

This map shows the geographic impact of Vincent J. Picozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent J. Picozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent J. Picozzi more than expected).

Fields of papers citing papers by Vincent J. Picozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent J. Picozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent J. Picozzi. The network helps show where Vincent J. Picozzi may publish in the future.

Co-authorship network of co-authors of Vincent J. Picozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent J. Picozzi. A scholar is included among the top collaborators of Vincent J. Picozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent J. Picozzi. Vincent J. Picozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study (RAMP 205). 2024 ·Journal of Clinical Oncology ·Kian‐Huat Lim, Kristen Spencer, Rachael A. Safyan, Vincent J. Picozzi, Anna M. Varghese, Despina Siolas, Kimberly Perez, (unknown), (unknown), Vijeta Bhambhani, (unknown), Jonathan A. Pachter, Philippe Pultar, Manuel Hidalgo	9
2	Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma 2024 ·American Journal of Clinical Pathology ·(unknown), Lucia Roa‐Peña, Sruthi Babu, (unknown), Emanuel F. Petricoin, Lynn M. Matrisian, Edik M. Blais, Natalia Marchenko, Felicia D. Allard, Ali Akalin, Wei Jiang, Brent K. Larson, Andrew Hendifar, Vincent J. Picozzi, Minsig Choi, Kenneth R. Shroyer, Luisa F. Escobar‐Hoyos	1
3	Management of Patients With Pancreatic Cancer Using the “Right Track” Model 2023 ·The Oncologist ·Allison Rosenzweig, Jordan Berlin, Suresh T. Chari, Hedy L. Kindler, Lynn M. Matrisian, (unknown), (unknown), Nicholas N. Nissen, Vincent J. Picozzi, (unknown), Jason B. Fleming	10
4	A randomized phase II study of SM‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond 2022 ·Cancer Medicine ·Marcus Smith Noel, Semmie Kim, Marion L. Hartley, (unknown), Vincent J. Picozzi, Harry Staszewski, Dae Won Kim, Jan M. Van Tornout, Philip Agop Philip, Vincent Chung, Allyson J. Ocean, Andrea Wang‐Gillam	6
5	550P Initial results of a phase Ia/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors 2021 ·Annals of Oncology ·Rishi Jain, (unknown), H.J. Lenz, Wells A. Messersmith, Vincent J. Picozzi, Muhammad Shaalan Beg, Benjamin A. Weinberg, Devalingam Mahalingam, (unknown), (unknown), Joshua S. Lichtman, (unknown), Laura McDonald, Alex M. DePaoli, J. Zha, Andrew Hendifar	4
6	SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC) 2019 ·Annals of Oncology ·Mary Noel, (unknown), Allyson J. Ocean, Saurabh Chawla, Vincent Chung, (unknown), Vincent J. Picozzi	1
7	Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy 2019 ·Clinical Proteomics ·Hong Peng, Ru Chen, Teresa A. Brentnall, Jimmy K. Eng, Vincent J. Picozzi, Sheng Pan	15
8	Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative 2018 ·Clinical Cancer Research ·Michael J. Pishvaian, R Joseph Bender, (unknown), Lola Rahib, Andrew Hendifar, Sameh Mikhail, Vincent Chung, Vincent J. Picozzi, Davendra Sohal, Edik M. Blais, Kimberly Mason, Emily E. Lyons, Lynn M. Matrisian, Jonathan R. Brody, Subha Madhavan, Emanuel F. Petricoin	149
9	Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma? 2018 ·HPB ·Jesse Clanton, (unknown), Stephen J. Kaplan, Emily L. Johnson, Andrew S. Ross, (unknown), Adnan Alseidi, Thomas Biehl, Vincent J. Picozzi, W. Scott Helton, David Coy, Russell Dorer, Flavio G. Rocha	6
10	Results from a phase 2b, randomized, multicenter study of GVAX pancreas and CRS-207 compared to chemotherapy in adults with previously-treated metastatic pancreatic adenocarcinoma (ECLIPSE Study). 2017 ·Journal of Clinical Oncology ·Dung T. Le, Andrew H. Ko, Zev A. Wainberg, Vincent J. Picozzi, Hedy L. Kindler, Andrea Wang‐Gillam, Paul E. Oberstein, Michael A. Morse, Herbert J. Zeh, Colin D. Weekes, Tony R. Reid, Aimee Murphy, (unknown), Chan C. Whiting, Nitya Nair, Amanda Enstrom, Sandy Ferber, Thomas W. Dubensky, Dirk G. Brockstedt, Elizabeth M. Jaffee	39
11	A phase 1/2 study of metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer 2017 ·Annals of Oncology ·Vincent J. Picozzi, Vaibhav Sahai, Diane M. Simeone, (unknown), Allyson J. Ocean, Philip Philip, (unknown), Aparna Kalyan, Michael S. Ondovik, (unknown), Chrystal U. Louis	1
12	FG-3019, A Human Monoclonal Antibody to Connective Tissue Growth Factor, Combined with Chemotherapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma 2016 ·Vincent J. Picozzi, J. Marc Pipas, Albert C. Koong, Amato J. Giaccia, Nathan Bahary, Smitha Krishnamurthi, Charles D. Lopez, Peter J. O’Dwyer, Katharina Modelska, (unknown), James Chou, Ming Zhong, Stefan Hemmerich, Dongxia Li, Ewa Carrier, Seth Porter, Thomas B. Neff, Frank H. Valone	8
13	First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors 2015 ·Clinical Cancer Research ·Alexander Starodub, Allyson J. Ocean, Manish A. Shah, Michael J. Guarino, Vincent J. Picozzi, Linda T. Vahdat, Sajeve Thomas, Serengulam V. Govindan, Pius Maliakal, William A. Wegener, Steven A. Hamburger, Robert M. Sharkey, David M. Goldenberg	252
14	Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer 2015 ·Annals of Surgery ·Flavio G. Rocha, (unknown), L. William Traverso, Russell Dorer, Richard A. Kozarek, W. Scott Helton, Vincent J. Picozzi	21
15	Supportive Care Considerations During Concurrent Chemoradiotherapy for Pancreatic Adenocarcinoma 2012 ·American Journal of Clinical Oncology ·Andrea Wang‐Gillam, Ross A. Abrams, Mitchell C. Posner, Peter W. T. Pisters, Vincent J. Picozzi	4
16	Afferent limb syndrome and delayed GI problems after pancreaticoduodenectomy for pancreatic cancer: single-center, 14-year experience 2011 ·Gastrointestinal Endoscopy ·Rahul Pannala, John J. Brandabur, S. Ian Gan, Michael Glück, Shayan Irani, David J. Patterson, Andrew S. Ross, Russell Dorer, L. William Traverso, Vincent J. Picozzi, Richard A. Kozarek	76
17	Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement 2009 ·Annals of Surgical Oncology ·Ross A. Abrams, Andrew M. Lowy, Eileen M. O’Reilly, Robert A. Wolff, Vincent J. Picozzi, Peter W. T. Pisters	196
18	Anemia in the Elderly: A Public Health Crisis in Hematology 2005 ·Hematology ·Jack M. Guralnik, William B. Ershler, Stanley L. Schrier, Vincent J. Picozzi	119
19	Novel approaches to postoperative chemoradiation therapy in pancreatic cancer 2001 ·Journal of Gastrointestinal Surgery ·Vincent J. Picozzi	2
20	Cardiac Tamponade Due to Primary Pericardial Lymphoma in a Patient With AIDS 1994 ·CHEST Journal ·David M. Aboulafia, Roger W. Bush, Vincent J. Picozzi	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact